David J Jackson

30PUBLICATIONS

164CO-AUTHORS

Ngā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Gene and molecular therapyOrganic geochemistryCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromolecules

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|Jun 24, 2026

Reply to Siddiqui et al., Godbout et al., and to Chang and Mao.

|Feb 25, 2026

Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: a multicenter, randomized, double-blind, phase 3A clinical trial (NIMBLE).

Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch

|Feb 25, 2026

Fractional exhaled nitric oxide as a novel biomarker of relapse in eosinophilic granulomatosis with polyangiitis.

Francesca Cefaloni, Anne-Catherine Maynard-Paquette, Ajerico Del Rosario

|May 30, 2025

Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction.

Renaud Louis, Marek Lommatzsch, David J Jackson

|May 14, 2025

Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.

Jessica Gates, Faizan Haris, Francesca Cefaloni

|Apr 11, 2025

Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

I Agache, I M Adcock, C A Akdis

Pageof 5

Frequent Collaborators

Luis Perez-de-Llano

Jaideep Dhariwal

Ioana Agache

Ian M Adcock

Cezmi A Akdis

David B Price

Peter Howarth

Maria J Torres

Asma Raheem

C Boccabella

Frequent Collaborators

Luis Perez-de-Llano

Jaideep Dhariwal

Ioana Agache

Ian M Adcock